skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Evaluation of Effectiveness of Embolization in Pelvic Congestion Syndrome with the New Vascular Occlusion Device (ArtVentive EOS™): Preliminary Results

Abstract

PurposeThis study aimed to collect confirmatory data in support of the safety and efficiency of the ArtVentive EOS™ for the treatment of the pelvic congestion syndrome (PCS). This study was based on the OCCLUDE 1 Study Protocol approved by the Local Ethics Committee.Materials and MethodsA prospective study carried out in June and July 2014 included 12 women aged 21–48 years (mean 31 years) scheduled for PCS embolization using the ArtVentive EOS™. The inclusion criteria were clinical symptoms of PCS documented by transvaginal Doppler ultrasound and pelvic MRI. The pelvic pain was assessed by VAS score from 0 to 10 (0 represents lack of pain and 10 unbearable pain). A decrease in pelvic pain intensity based on the VAS was considered a clinical success.ResultsSuccessful embolization procedures with ArtVentive EOS™ were performed in 11 out of 12 patients. Nine patients underwent unilateral embolization of the left ovarian vein, and two had bilateral embolization of the ovarian veins. Complete ovarian vein occlusion confirmed by post deployment venography was achieved in all 11 patients. Procedures lasted from 19 to 45 min (average 28 min). Pain intensity decrease was observed in all 11 patients—a decrease of 5.6 points—from 7.3 pre-procedure to 1.6 post-embolization (standard deviation: 0.67). In one case,more » the left ovarian vein was injured by guide wire manipulation with contrast extravasation—not clinically significant.ConclusionsThe use of ArtVentive EOS™ for occlusion of the ovarian veins in PCS patients is safe and effective.« less

Authors:
 [1];  [2]; ; ;  [1]
  1. Medical University of Lublin, Department of Interventional Radiology and Neuroradiology (Poland)
  2. Medical University of Lublin, III Gynecology Clinic (Poland)
Publication Date:
OSTI Identifier:
22645472
Resource Type:
Journal Article
Resource Relation:
Journal Name: Cardiovascular and Interventional Radiology; Journal Volume: 39; Journal Issue: 8; Other Information: Copyright (c) 2016 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Article Copyright (c) 2016 The Author(s); http://www.springer-ny.com; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; EFFICIENCY; ELDERLY PEOPLE; EQUIPMENT; ETHICAL ASPECTS; EVALUATION; NMR IMAGING; OVARIES; PAIN; PATIENTS; SAFETY; VASCULAR DISEASES; VEINS; WOMEN

Citation Formats

Pyra, Krzysztof, E-mail: k.pyra@poczta.fm, Woźniak, Sławomir, E-mail: slavwo7572@gmail.com, Drelich-Zbroja, Anna, E-mail: zbroanna@interia.pl, Wolski, Andrzej, E-mail: andrzej.s.wolski@gmail.com, and Jargiełło, Tomasz, E-mail: tojarg@interia.pl. Evaluation of Effectiveness of Embolization in Pelvic Congestion Syndrome with the New Vascular Occlusion Device (ArtVentive EOS™): Preliminary Results. United States: N. p., 2016. Web. doi:10.1007/S00270-016-1380-8.
Pyra, Krzysztof, E-mail: k.pyra@poczta.fm, Woźniak, Sławomir, E-mail: slavwo7572@gmail.com, Drelich-Zbroja, Anna, E-mail: zbroanna@interia.pl, Wolski, Andrzej, E-mail: andrzej.s.wolski@gmail.com, & Jargiełło, Tomasz, E-mail: tojarg@interia.pl. Evaluation of Effectiveness of Embolization in Pelvic Congestion Syndrome with the New Vascular Occlusion Device (ArtVentive EOS™): Preliminary Results. United States. doi:10.1007/S00270-016-1380-8.
Pyra, Krzysztof, E-mail: k.pyra@poczta.fm, Woźniak, Sławomir, E-mail: slavwo7572@gmail.com, Drelich-Zbroja, Anna, E-mail: zbroanna@interia.pl, Wolski, Andrzej, E-mail: andrzej.s.wolski@gmail.com, and Jargiełło, Tomasz, E-mail: tojarg@interia.pl. Mon . "Evaluation of Effectiveness of Embolization in Pelvic Congestion Syndrome with the New Vascular Occlusion Device (ArtVentive EOS™): Preliminary Results". United States. doi:10.1007/S00270-016-1380-8.
@article{osti_22645472,
title = {Evaluation of Effectiveness of Embolization in Pelvic Congestion Syndrome with the New Vascular Occlusion Device (ArtVentive EOS™): Preliminary Results},
author = {Pyra, Krzysztof, E-mail: k.pyra@poczta.fm and Woźniak, Sławomir, E-mail: slavwo7572@gmail.com and Drelich-Zbroja, Anna, E-mail: zbroanna@interia.pl and Wolski, Andrzej, E-mail: andrzej.s.wolski@gmail.com and Jargiełło, Tomasz, E-mail: tojarg@interia.pl},
abstractNote = {PurposeThis study aimed to collect confirmatory data in support of the safety and efficiency of the ArtVentive EOS™ for the treatment of the pelvic congestion syndrome (PCS). This study was based on the OCCLUDE 1 Study Protocol approved by the Local Ethics Committee.Materials and MethodsA prospective study carried out in June and July 2014 included 12 women aged 21–48 years (mean 31 years) scheduled for PCS embolization using the ArtVentive EOS™. The inclusion criteria were clinical symptoms of PCS documented by transvaginal Doppler ultrasound and pelvic MRI. The pelvic pain was assessed by VAS score from 0 to 10 (0 represents lack of pain and 10 unbearable pain). A decrease in pelvic pain intensity based on the VAS was considered a clinical success.ResultsSuccessful embolization procedures with ArtVentive EOS™ were performed in 11 out of 12 patients. Nine patients underwent unilateral embolization of the left ovarian vein, and two had bilateral embolization of the ovarian veins. Complete ovarian vein occlusion confirmed by post deployment venography was achieved in all 11 patients. Procedures lasted from 19 to 45 min (average 28 min). Pain intensity decrease was observed in all 11 patients—a decrease of 5.6 points—from 7.3 pre-procedure to 1.6 post-embolization (standard deviation: 0.67). In one case, the left ovarian vein was injured by guide wire manipulation with contrast extravasation—not clinically significant.ConclusionsThe use of ArtVentive EOS™ for occlusion of the ovarian veins in PCS patients is safe and effective.},
doi = {10.1007/S00270-016-1380-8},
journal = {Cardiovascular and Interventional Radiology},
number = 8,
volume = 39,
place = {United States},
year = {Mon Aug 15 00:00:00 EDT 2016},
month = {Mon Aug 15 00:00:00 EDT 2016}
}